New hope for millions: experimental drug battles hepatitis b
NCT ID NCT07203118
Summary
This large clinical trial is testing a new medication called hepenofovir for people with chronic hepatitis B. Researchers are comparing different doses against a standard treatment to find the most effective and safest option. The goal is to better control the hepatitis B virus long-term in patients who haven't taken certain antiviral medications recently.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Hospital of Jilin University
Jilin, changchun, China
Conditions
Explore the condition pages connected to this study.